Jim Pearce

Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.

Analyst Articles

What if you held a party and nobody came? RGR released fourth quarter and full-year 2016 results on February 22 that reflected a 21% increase in net sales and 43% jump in earnings per share, but even that wasn’t enough to break the stock out of its narrow trading… Read More

I bought KSS in January on the belief that investors had overreacted to weak holiday sales figures from the retail sector, and based on Kohl’s better than feared quarterly report issued last week it appears that assumption is proving true. At the end of February we had a 3%… Read More

I waited until after JONE released its full year guidance for 2017 before issuing our buy alert on February 23, believing that would remove most of the near-term risk in the stock. Turns out I was wrong about that, as its share price dropped more than 10% the following… Read More

It’s been a rocky road during our first six weeks in this position, but we have managed to eke out a small gain in CVS despite a big drop the week after we bought it on January 26. After bottoming out below $75 on February 2, CVS climbed steadily upward… Read More

CSCO was our top performing holding in February, gaining nearly 11% for the month which accounts for the bulk of its 12% increased since we added it to our portfolio on December 21. The month of January was fairly quiet until the company announced its proposed acquisition of AppDynamics, and since… Read More

Ten days after opening this position in CATO on February 1, I was feeling pretty smart. The stock had gained nearly 8% and appeared to be making a beeline for our $29 target price. Ten days after that it was apparent that the stock had run out of momentum, and… Read More

CARB has only been in our portfolio a few weeks so it is too soon to start keeping score. We waited until after its most recent quarterly earnings report was released on February 9 to buy it to avoid the possibility of a surprise to the downside. That caution… Read More

After methodically grinding out a 5% share price increase since being added to our portfolio on January 5, Best Buy gave all of that back on March 1 after releasing a mixed quarterly earnings report. However, the very next day it gained all of that back, recovering our gain in… Read More